medigraphic.com
ISSN 1729-519X (Print)

2016, Number 4

<< Back Next >>

Revista Habanera de Ciencias Médicas 2016; 15 (4)

Influence of comorbidity on patients evolution with upper gastrointestinal bleeding from peptic ulcer

Infante VM, Román MY, Winograd LR, Ramos CJY, Rodríguez ÁD, Corujo AE

Language: Spanish
References: 34
Page: 551-562
PDF size: 122.74 Kb.


ABSTRACT

Introduction: Despite the endoscopic therapy advances, morbidity and mortality of patients with gastrointestinal bleeding are high.
Objective: To determine if there is relationship between comorbidity and its severity with short-term developments in the ulcerative patient presenting acute upper gastrointestinal bleeding episode.
Material and Methods: We performed an observational, descriptive, prospective and longitudinal research in the Central Military Hospital "Dr. Luis Díaz Soto" between September 2013 and March 2015. 103 patients that bled due to peptic ulcer were included. The bleeding stigmas were identified by means of Forrest classification, correspondently; endoscopic therapy was applied and assessed using the Charlson Comorbidity Index. Comparisons between the groups with and without comorbidity and gravely ill regarding treatment results, rebleeding, surgery and mortality were made.
Results: Male patients predominated (69.9%) and older than 60 years old (62.7 ± 17.8 years). 58.3% presented comorbidity. The condition most prevalent was ischemic heart disease (21.4%). Among patients with co-morbidity existed higher probability of finding during endoscopy of acute bleeding stigmata or recent bleeding (RR = 1 2; IC 95% = 0.48-2.98). The rebleeding risk was higher among those who had moderate comorbidity (RR = 1. 5; 95% CI: 0.25-8.97; (p = 0.006). The need for surgery was not related to co-morbidity. Mortality was precocious (21.4%) and was related to the coexistence of hepatic cirrhosis.
Conclusions: The greater influence of co-morbid diseases occurs on bleeding relapse and mortality.


REFERENCES

  1. Kalkan Ç, Soykan I, Karakaya F, Tüzün A, Gençtürk ZB.Comparison of three scorıng systems for risk stratifıcation in elderly patıents wıth acute upper gastrointestinal bleedıng. Geriatr Gerontol Int [Internet]. 2016. [Citado 2016 May 29]. Disponible en: http://dx.doi.org/10.1111/ggi.12757

  2. Corzo Maldonado MA, Guzmán Rojas P, Bravo Paredes EA, Gallegos López RC, Huerta Mercado-Tenorio J, Surco Ochoa Y, et al. Factores de riesgo asociados a la mortalidad por hemorragia digestiva alta en pacientes de un hospital público: Estudio caso control.Rev Gastroenterol Perú [Internet]. 2013; 33:223-9 pp. [Citado 2015 Oct 10]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022- 51292013000300004&nrm=iso

  3. Dicu D, Pop F, Ionescu D, Dicu T. Comparison of risk scoring systems in predicting clinical outcome at upper gastrointestinal bleeding patients in an emergency unit. Am J Emerg Med [Internet]. 2013 Jan, 31(1):94-9 pp. [Citado 2015 Oct 23]. Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0735-6757(12)00334-8

  4. Castillo-Elera C, Montenegro-Idrogo JJ, Montañez-Valverde R, Callupe-Huamán G, Huayta-Córdova G, Rivera-Fernández G, et al. Incidencia y factores asociados en la recurrencia de sangrado ulceroso post inyectoterapia con adrenalina. Rev Gastroenterol Perú [Internet]. 2012; 32:351-6 pp. [Citado 2015 Nov 12]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022- 51292012000400003&nrm=iso

  5. Winograd Lay R, Williams Guerra E, Rodríguez Álvarez D, Ramos Contreras JY, Guisado Reyes Y, Angulo Pérez O, et al. Endoscopía en la atención a pacientes con hemorragia digestiva alta no varicosa. Rev Cubana Med Mil [Internet]. 2015; 44:187- 94 pp. [Citado 2016 Ene 23]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 65572015000200007&nrm=iso

  6. Pozo González A, Corimayta Gutierrez Y, Jaime Carballo Y, Barbán Fernández L, Brizuela Pérez SM. Características clínicas del sangramiento digestivo alto. AMC [Internet]. 2010; 14. [Citado 2015 Nov 16]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025- 02552010000300008&nrm=iso

  7. Acosta González D, Rodríguez Fernández Z, Fong Estrada JA, Pagés Gómez O. Caracterización del paciente anciano con hemorragia digestiva alta MEDISAN [Internet]. 2009; 13(2). [Citado 2015 Dic 26]. Disponible en: http://bvs.sld.cu/revistas/san/vol13_2_09/san01209.htm

  8. Åhsberg K, Höglund P, Staël von Holstein C. Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding. Aliment Pharmacol Ther [Internet]. 2010; 32(6):801-10 pp. [Citado 2016 May 29]. Disponible en: http://dx.doi.org/10.1111/j.1365-2036.2010.04399.x

  9. Bae S, Kim N, Kang JM, Kim D-S, Kim K-M, Cho YK, et al. Incidence and 30-day mortality of peptic ulcer bleeding in Korea. Eur J Gastroenterol Hepatol [Internet]. 2012; 24(6):675-82 pp.. [Citado 2016 May 23]. Disponible en: http://journals.lww.com/eurojgh/Fulltext/2012/06000/Incidence_and_30_day_mortali ty_of_peptic_ulcer.10.aspx

  10. Coskun F, Topeli A, Sivri B. Patients admitted to the emergency room with upper gastrointestinal bleeding: factors influencing recurrence or death. Adv Ther [Internet]. 2005 Sep-Oct; 22(5):453-61 pp. [Citado 2015 Nov 24]. Disponible en: http://link.springer.com/article/10.1007/BF02849865

  11. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2(7877):394-7.

  12. Charlson M, Pompei P, Ales K, McKenzie R. A new method of classifyging prognostic comorbidity in longitudinal studies: development and validation. J Chr Dis. 1987;40:373-83.

  13. Weil J, Langman MJS, Wainwright P, Lawson DH, Rawlins M, Logan RFA, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal antiinflammatory drugs. Gut [Internet]. 2000; 46(1):27-31 pp. [Citado 2014 Abr 17]. Disponible en: http://gut.bmj.com/content/46/1/27.full

  14. Gallerani M, Simonato M, Manfredini R, Volpato S, Vigna GB, Fellin R. Risk of hospitalization for upper gastrointestinal tract bleeding. J Clin Epidemiol. 2004;57(1):103-10.

  15. Al-Mallah M, Bazari RN, Jankowski M, Hudson MP. Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes. J Thromb Thrombolysis [Internet]. 2007 Feb; 23(1):51-5 pp. [Citado 2015 Nov 04]. Disponible en: http://link.springer.com/article/10.1007/s11239-006-9005- 8/fulltext.html?view=classic

  16. Lanas A, Aabakken L, Fonseca J, Mungan ZA, Papatheodoridis GV, Piessevaux H, et al. Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. Aliment Pharmacol Ther [Internet]. 2011 Jun; 33(11):1225-33 pp. [Citado 2016 Ene 18]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2011.04651.x/full

  17. Stack WA, Atherton JC, Hawkey GM, Logan RFA, Hawkey CJ. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther [Internet]. 2002; 16(3):497-506 pp. [Citado 2015 Jul 12]. Disponible en: http://dx.doi.org/10.1046/j.1365-2036.2002.01197.x.

  18. Kuo CC, Kuo HW, Lee IM, Lee CT, Yang CY. The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study. BMC Nephrol [Internet]. 2013; 14:15 p. [Citado 2015 Nov 22]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558322/#

  19. Wilcox CM, Cryer BL, Henk HJ, Zarotsky V, Zlateva G. Mortality associated with gastrointestinal bleeding events: Comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial infarction in a US managed care setting. Clin Exp Gastroenterol [Internet]. 2009; 2:21-30 pp. [Citado 2015 Mar 31]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108636/#

  20. Crooks CJ, West J, Card TR. Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding. Gastroenterology [Internet]. 2013; 144(7):1384-93.e2 pp. [Citado 2016 Ene 18]. Disponible en: http://www.gastrojournal.org/article/S0016- 5085(13)00289-8/full

  21. Morales Uribe CH, Sierra Sierra S, Hernández Hernández AM, Arango Durango AF, López GA. Hemorragia digestiva alta: factores de riesgo para la mortalidad en dos centros urbanos en Latinoamérica. Rev Esp Enferm Dig [Internet]. 2011; 103(1):20-4 pp. [Citado 2015 Jun 09]. Disponible en: http://www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt=4619314&TO =RVN&Eng=1

  22. Hernández Ortega A, Sánchez Cruz J, Álvarez Díaz M, Figueroa Vázquez A, Yanes Castellanos L. Comportamiento del sangramiento digestivo alto en pacientes endoscopiados. Rev Méd Electrón [Internet]. 2006; 28(4). [Citado 2016 May 29]. Disponible en: http://www.revmatanzas.sld.cu/revista%20medica/ano%202006/vol4%202006/tema 05.htm

  23. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J. 2004;147(1):91-9.

  24. Luo JC, Leu HB, Hou MC, Huang CC, Lin HC, Lee FY, et al. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther [Internet]. 2012;36(6):542-50 pp. [Citado 2015 01 18]. Disponible en: http://dx.doi.org/10.1111/j.1365-2036.2012.05225.x

  25. Liang C-C, Wang S-M, Kuo H-L, Chang C-T, Liu J-H, Lin H-H, et al. Upper gastrointestinal bleeding in patients with CKD. Clin J Am Soc Nephrol [Internet]. 2014 June 5, 2014. [Citado 2015 Ene 18]. Disponible en: http://cjasn.asnjournals.org/content/early/2014/06/04/CJN.09260913.full

  26. Ang D, Teo EK, Tan A, Ibrahim S, Tan PS, Ang TL, et al. A comparison of surgery versus transcatheter angiographic embolization in the treatment of nonvariceal upper gastrointestinal bleeding uncontrolled by endoscopy. Eur J Gastroenterol Hepatol [Internet]. 2012 Aug; 24(8):929-38 pp. [Citado 2015 May 28]. Disponible en: www.gastrojournal.org/article/S0016-5085(12)61929-5/pdf

  27. Manrique M. Eficacia de la hemostasia en la hemorragia digestiva alta de origen no variceal. Rev Hosp Jua Mex [Internet]. 2010;77(2):93-7 pp. [Citado 2014 Nov 23]. Disponible en: www.medigraphic.com/pdfs/juarez/ju-2010/ju102c.pdf

  28. Jepsen P, Vilstrup H, Lash TL. development and validation of a comorbidity scoring system for patients with cirrhosis. Gastroenterology [Internet]. 2013; 146(1):147-56 pp. [Citado 2015 Oct 14]. Disponible en: http://www.gastrojournal.org/article/S0016-5085(13)01347-4/fulltext.

  29. Bang CS, Baik GH, Kim JH, Kim JB, Suk KT, Yoon JH, et al. Peptic ulcer disease in liver cirrhosis and chronic hepatitis: impact of portal hypertension. Scand J Gastroenterol [Internet]. 2014; 49(9):1051-7 pp. [Citado 2015 Nov 01]. Disponible en: http://informahealthcare.com/doi/abs/10.3109/00365521.2014.923501

  30. Chang S-S, Hu H-Y. Early Helicobacter pylori eradication is associated with a reduced risk of recurrent peptic ulcers in cirrhotic patients. J Digest Dis [Internet]. 2014; 15(8):451-8 pp. [Citado 2015 Jul 20]. Disponible en: http://dx.doi.org/10.1111/1751-2980.12159

  31. Leontiadis GI, Molloy-Bland M, Moayyedi P, Howden CW. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: systematic review and meta-analysis. Am J Gastroenterol [Internet]. 2013;108(3):331-45 pp. [Citado 2015 Sep 14]. Disponible en: http://dx.doi.org/10.1038/ajg.2012.451

  32. Laursen SB, Hansen JM, Hallas J, Schaffalitzky de Muckadell OB. The excess longterm mortality in peptic ulcer bleeding is explained by nonspecific comorbidity. Scand J Gastroenterol [Internet]. 2015; 50(2):145-52 pp. [Citado 2016 Ene 18]. Disponible en: http://dx.doi.org/10.3109/00365521.2014.992365

  33. Gopalswamy N, Malhotra V, Reddy N, Singh BM, Markert RJ, Sangal S, et al. Long-term mortality of patients admitted to the intensive care unit for gastrointestinal bleeding. South Med J. 2004;97(10):955-8.

  34. Matei D, Cruciat C, Furnea B, Levi C, Groza I, Puie L, et al. Sa1890 The Impact of comorbidities on 30-day mortality in peptic ulcer bleeding. Gastroenterology [Internet]. 2014;146(5):S-321 pp. [Citado 2015 Nov 21]. Disponible en: http://www.gastrojournal.org/article/S0016-5085(14)61159-8/abstract




2020     |     www.medigraphic.com